Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
A Phase II Trial of an Extended-Release siRNA Implant Targeting KRASG12D/V in Locally Advanced Pancreatic Cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: August 23, 2025
Oncogenic KRAS engages an RSK1/NF1 pathway to inhibit wild-type RAS signaling in pancreatic cancer.
Journal: Proceedings of the National Academy of Sciences of the United States of America
Published: May 22, 2021
Intraductal Transplantation Models of Human Pancreatic Ductal Adenocarcinoma Reveal Progressive Transition of Molecular Subtypes.
Journal: Cancer discovery
Published: January 31, 2020
The glycan CA19-9 promotes pancreatitis and pancreatic cancer in mice.
Journal: Science (New York, N.Y.)
Published: December 08, 2018
Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer.
Journal: Cancer discovery
Published: December 01, 2018
Combined MEK and PI3K inhibition in a mouse model of pancreatic cancer.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: October 29, 2014
TGF-β and αvβ6 integrin act in a common pathway to suppress pancreatic cancer progression.
Journal: Cancer research
Published: July 13, 2012
Prostaglandin D2 inhibits hair growth and is elevated in bald scalp of men with androgenetic alopecia.
Journal: Science translational medicine
Published: March 24, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026